Ventricular fibrillation | Atrial fibrillation | |
---|---|---|
Patients (n) | 30 | 10 |
Women (n) | 3 | 3 |
Mean (SD) age (years) | 58 (7) | 57 (14) |
Range | 41–76 | 29–74 |
Cardiovascular disease (n) | ||
Coronary artery disease | 25 | 4 |
One vessel | 14 | 0 |
Two vessel | 4 | 2 |
Three vessel | 7 | 2 |
Previous myocardial infarction | 23 | 3 |
Anterior (-lateral) wall | 15 | 3 |
Posterior (-lateral) wall | 11 | 1 |
Dilated cardiomyopathy | 4 | 0 |
Aortocoronary venous bypass | 3 | 2 |
Left ventricular ejection fraction (%) | 47 (20) | 60 (15)1-150 |
NYHA class | 2.1 (0.6) | 1.9 (0.7) |
Digitalis medication (n) | 7 | 9 |
Analgesics/sedatives | ||
Midazolam (μg/kg) | 116 (43) | 71 (26) |
Fentanyl (μg/kg) | 34 (12) | 31 (10) |
Etomidate (μg/kg) | 0 | 119 (53) |
Values are means (SD).
↵1-150 p < 0.05 for intergroup difference.
NYHA, New York Heart Association.